- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Mark Kris Explains the Changing Roles of Physicians and Human Genomes
As the human genome becomes more of a part of standard care, both the physician's responsibilities to his or her patients and the way care is delivered changes, explained Mark Kris, MD, William and Joy Ruane chair in thoracic oncology at Memorial Sloan Kettering Cancer Center.
As the human genome becomes more of a part of standard care, both the physician’s responsibilities to his or her patients and the way care is delivered changes, explained Mark Kris, MD, William and Joy Ruane chair in thoracic oncology at Memorial Sloan Kettering Cancer Center.
He said that physicians need to learn how to understand and interpret the genetic information put before them because this information is integral to the whole care of the patient.
“It makes [the physician’s] job a lot easier sometimes and a lot harder sometimes,” Dr Kris said. “Also with all of these changes, there’s not a clear path as to what’s the right thing to do.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
